The Platform
Designed in living immune cells. Selected for function. Built to outlast antigen escape.
The kill event.
A T-cell engager bridges T cell and tumour cell — activating a targeted immune response. Precise. Programmable. Repeatable.
01 What We Build
Trispecifics, bispecifics, and VHH-based formats — designed on one modular architecture, validated in primary human immune cells.
02 How We Design Them
Our AI trains on T-cell killing, activation, and cytokine profiles — selecting for function, not binding.
03 OR-Gate Architecture
Our OR-gated multispecifics require tumour cells to lose both independent antigens to escape — closing two routes simultaneously, where AND-gate designs leave one open.
04 Speed
Target to clinical candidate in months, not years.